VERO /MHI-TM2000 linear accelerator system with software version 3.0.0 and after 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 Mitsubishi Heavy Industries Ltd 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2014-07-22
  • 사례 출판 날짜
    2014-07-22
  • 사례 국가
  • 사례 출처
    DH
  • 사례 출처 URL
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • 데이터 추가 비고
    Medical Device Safety Alert
  • 원인
    Medical device safety alert: mitsubishi vero /mhi-tm2000 linear accelerator system with software version 3.0.0 and after the medicines and healthcare products regulatory agency (mhra), united kingdom posted a field safety notice concerning vero /mhi-tm2000 linear accelerator system with software version 3.0.0 and after, manufactured by mitsubishi heavy industries ltd. accordingbased on internal investigation, the manufacturer found incorrectness with the condition set for rescheduling untreated fractions after the calendar setting is made. the record and verify system (r&v system) of the vero /mhi-tm2000 linear accelerator system has a calendar function used for treatment scheduling. because of a software bug, an unintended fraction is added to treatment schedule when holiday/workday setting is changed. according to the manufacturer, in case an added fraction is not detected by the user, unnecessary dose for the fraction will be given to the patient. it can cause death or serious injury of a patient depending on the treatment. the manufacturer advises users not to change calendar setting - from workday to holiday or vice versa - in r&v system until correction becomes available. however, if users must change the calendar setting, they must confirm whether any treatments, which are to be completed on the day that change is made, are added to each patient’s treatment schedule list as well as correct it manually when they find incorrect rescheduling. in addition, if users have to change treatment schedule in r&v system, the manufacturer reminds them to double-check the number of the fractions, date and time of the schedule each time until correction becomes available. if any unintended fraction is detected, it should be corrected manually. the manufacturer will contact all affected customers to schedule its installation. the tentatively planned availability date is end of august 2014. the manufacturer is creating a software tool to automatically check inconsistencies of patient treatment fractions in r&v system database. if an inconsistency problem is found, the manufacturer will further investigate it in collaboration with the customer to determine whether a potential mistreatment exists. for details, please refer to mhra website: http://www.Mhra.Gov.Uk/home/groups/fsn/documents/fieldsafetynotice/con435839.Pdf if you are in possession of the affected products, please contact your supplier for necessary actions. posted on 22 july 2014.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    Medical Device Safety Alert: Mitsubishi VERO /MHI-TM2000 linear accelerator system with software version 3.0.0 and after
  • Manufacturer

Manufacturer